$1.08
0.1617.52%
Last update: Nov 12, 7:12 PM
Skye Bioscience Inc
SKYENASDAQ
Skye Bioscience fell 90.1% from $10.96 to $1.08, behind the S&P 500's +12.7%. Its worst day was Nov 9 (−30.3%), and its low came Nov 9 at $0.69.
Nov 13, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Skye Bioscience closed at its highest level of the year, 2.2% above where the year started.
+7.7% · S&P 500 −0.9%
Skye Bioscience shares rose 17.7%, while the S&P 500 rose 0.6%.
+17.7% · S&P 500 +0.6%
Story events cover the past 12 months · Times ET
EPS of $-2.88 missed the $-2.40 estimate on $0.00 revenue.
−9.7% · S&P 500 −0.1%
EPS of $-2.56 beat the $-2.56 estimate on $0.00 revenue.
−7.6% · S&P 500 −0.2%
Skye Bioscience shares rose 16.0%, while the S&P 500 rose 0.4%.
+16.0% · S&P 500 +0.4%
Skye Bioscience shares fell 16.0%, while the S&P 500 fell 0.2%.
−16.0% · S&P 500 −0.2%
EPS of $-2.16 beat the $-2.16 estimate on $0.00 revenue.
−7.3% · S&P 500 −0.2%
Skye Bioscience shares fell 19.4%, while the S&P 500 fell 0.4%.
−19.4% · S&P 500 −0.4%
Skye Bioscience closed at its lowest level of the year, 93.7% below where the year started.
−30.3%, the year's worst day · S&P 500 +2.4%
Where it ended: a close of $1.08 on Nov 12, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-1.47).
Nothing in the past 12 months.
All SKYE analyst actionsNothing in the past 12 months.
All SKYE dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SKYE and SPY from Benzinga historical bars. Not investment advice.
